JPDA 2024 Annual Meeting Committees Joint Symposium Reforming pharmaceutical manufacturing by utilizing digital technology and AI

Abstract

Digital technologies and artificial intelligence (AI) are rapidly advancing in the field of pharmaceutical manufacturing, bringing about dramatic transformations within the industry. Member companies of the Japan PDA Pharmaceutical Association have also been actively adopting digital transformation (DX), and lively discussions on DX were held during individual committee sessions at the 2023 Annual Meeting. Based on this experience, at the 2024 Annual Meeting, the Association consolidated these previously separate committee discussions into a unified, three-and-a-half-hour joint symposium titled “Transforming Pharmaceutical Manufacturing through Digital Technology and AI.” This paper reports on the Committee Joint Symposium held on Thursday, December 5, 2024, during the Japan PDA Pharmaceutical Association 2024 Annual Meeting.